Targeting transgene to the heart and liver with AAV9 by different promoters-Reference-Cited by-同舟云学术

Targeting transgene to the heart and liver with AAV9 by different promoters

Published:2015-09-15 Issue:10 Volume:42 Page:1108-1117
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Chen Bang-Dang¹,He Chun-Hui¹²,Chen Xiao-Cui¹,Pan Shuo²,Liu Fen¹,Ma Xiang²,Li Xiao-Mei²,Gai Min-Tao¹,Tao Jing²,Ma Yi-Tong¹²,Yang Yi-Ning¹,Gao Xiao-Ming¹³

Affiliation:

1. Xinjiang Key Laboratory of Cardiovascular Disease; Clinical Medical Research Institute; Urumqi China

2. Department of Cardiology; First Affiliated Hospital of Xinjiang Medical University; Urumqi China

3. Baker IDI Heart and Diabetes Institute; Melbourne Australia

Funder

National Natural Science Foundation of China

Natural Science Foundation of Xinjiang Uygur Autonomous Region

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1440-1681.12453/fullpdf

Reference28 articles.

1. AAV vectors for cardiac gene transfer: Experimental tools and clinical opportunities;Pacak;Mol. Ther.,2011

2. Vectrology of adeno-associated viruses (AAV);Skubis-Zegadlo;Med. Wieku. Rozwoj.,2013

3. Cardiomyocyte-specific gene expression following recombinant adeno-associated viral vector transduction;Aikawa;J. Biol. Chem.,2002

4. Topoisomerase inhibition accelerates gene expression after adeno-associated virus-mediated gene transfer to the mammalian heart;Prasad;Mol. Ther.,2007

5. Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration;Bostick;Gene Ther.,2007

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating Prime Editing and Cellular Reprogramming as Novel Strategies for Genetic Cardiac Disease Modeling and Treatment;Current Cardiology Reports;2024-09-11

2. Characterization of AAV vectors: A review of analytical techniques and critical quality attributes;Molecular Therapy - Methods & Clinical Development;2024-09

3. Inhibition of miR-25 ameliorates cardiac and skeletal muscle dysfunction in aged mdx/utrn haploinsufficient (+/−) mice;Molecular Therapy - Nucleic Acids;2024-06

4. BDH1-mediated βOHB metabolism ameliorates diabetic kidney disease by activation of NRF2-mediated antioxidative pathway;Aging;2023-11-27

5. The mechanism and targeted intervention of the HIF-1 pathway in improving atherosclerotic heart's sensitivity to ischemic postconditioning;Free Radical Biology and Medicine;2023-11